GW's finance chief resigns
This article was originally published in Scrip
Executive Summary
GW Pharmaceuticals announced that, after ten years as finance director, David Kirk has informed the company that he intends to stand down from the Board on 1 June 2012. Mr Kirk will be succeeded by Adam David George, who has served as GW’s company secretary and group financial controller since 2007. Mr Kirk will continue to be available to the company in a consulting capacity for an agreed period of time.